Medicare Enrolled

Dr. James Leavitt, M.D.

Gastroenterology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
7500 SW 87TH AVE, Miami, FL 33173
3059130666
In practice since 2005 (20 years)
NPI: 1598740557 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leavitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leavitt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leavitt

Dr. James Leavitt is a gastroenterology in Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Leavitt performed 1,999 Medicare services across 586 unique beneficiaries.

Between the years covered by Open Payments, Dr. Leavitt received a total of $17,682 from 53 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leavitt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 14% volume in FL$ $17,682 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,999
Medicare services
Top 14% in FL for gastroenterology
586
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~100 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Infliximab infusion (Remicade)1,270$26$231
Office visit, established patient (20-29 min)199$71$237
Office visit, established patient (30-39 min)106$98$348
Removal of polyps or growths of large bowel using an endoscope with mechanical snare75$230$1,426
Blood draw (venipuncture)69$8$9
Chronic care management, first 20 min/month69$52$192
Upper GI endoscopy with biopsy44$54$1,194
Colonoscopy with biopsy38$84$1,496
Colorectal cancer screening; colonoscopy on individual at high risk34$204$1,103
New patient office visit (45-59 min)26$133$542
Administration of chemotherapy into vein, 1 hour or less23$109$1,000
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk23$208$1,095
New patient office or other outpatient visit, 15-29 minutes12$54$245
New patient office visit (30-44 min)11$84$358
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
63.5% high complexity
8.1% medium
28.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$17,682
Total received (2018-2024)
Avg $2,526/year across 7 years
Top 9% in FL for gastroenterology
53
Companies
343
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,922 (39.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,231 (35.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,529 (25.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,922
2023
$710
2022
$2,641
2021
$1,719
2020
$2,007
2019
$4,430
2018
$1,253

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Echosens North America, Inc.
$3,600
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,734
PENTAX of America, Inc.
$2,545
E.R. Squibb & Sons, L.L.C.
$1,760
Janssen Biotech, Inc.
$1,058
ABBVIE INC.
$1,043
Takeda Pharmaceuticals U.S.A., Inc.
$674
PFIZER INC.
$344
AbbVie, Inc.
$295
Medtronic, Inc.
$265
Daiichi Sankyo Inc.
$235
Boston Scientific Corporation
$226
Synergy Pharmaceuticals Inc
$200
Phathom Pharmaceuticals, Inc.
$191
BOSTON SCIENTIFIC CORPORATION
$184
AbbVie Inc.
$184
QOL Medical, LLC
$154
Janssen Scientific Affairs, LLC
$136
Olympus America Inc.
$128
GENZYME CORPORATION
$112
Gilead Sciences, Inc.
$102
Intercept Pharmaceuticals, Inc.
$94
Merck Sharp & Dohme Corporation
$91
RedHill Biopharma Inc.
$88
Endo Pharmaceuticals Inc.
$86
Ardelyx, Inc.
$83
Lilly USA, LLC
$82
FUJIFILM Medical Systems USA, Inc.
$73
Exact Sciences Corporation
$73
INTERCEPT PHARMACEUTICALS, INC.
$70
Shire North American Group Inc
$70
Covidien LP
$69
Romark Laboratories, LC
$54
Regeneron Healthcare Solutions, Inc.
$54
Ipsen Biopharmaceuticals, Inc
$52
Celgene Corporation
$51
Merck Sharp & Dohme LLC
$44
Johnson & Johnson Health Care Systems Inc.
$43
Ferring Pharmaceuticals Inc.
$39
Nestle HealthCare Nutrition Inc.
$39
Allergan Inc.
$35
Ironwood Pharmaceuticals, Inc
$29
Allergan, Inc.
$26
Celltrion USA Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
EVOKE PHARMA, INC.
$20
Aries Pharmaceuticals, Inc.
$19
Shionogi Inc
$17
UCB, Inc.
$17
Alfasigma USA, Inc.
$16
Braintree Laboratories, Inc.
$13
Prometheus Laboratories Inc.
$12
Napo Pharmaceuticals Inc
$8
Top 3 companies account for 50.2% of total payments
Associated products mentioned in payments ›
ACQUIRE · ARIETTA · Aemcolo · Alinia Tablets 500mg 30 count bottle · CIMZIA · CLENPIQ · CYLTEZO · CapsoCam Plus · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · ELEVIEW · ENTYVIO · EOHILIA · ESD - Core Endoscopy · Entyvio · Epclusa · FibroScan · GATTEX · GENERAL THERAPIES · GENERAL THERAPIES · GENERAL - THERAPIES · GI GENIUS · GIMOTI · General - Therapies · HUMIRA · Humira · IBSRELA · IMAGAGINA · IMAGINA · INFLECTRA · INJECTAFER · IQIRVO · LINZESS · Linzess · MOVIPREP · Mulpleta · Mytesi · N/A · NASCOBAL · OCALIVA · OMVOH · PillCam · RENFLEXIS · RINVOQ · Resolution 360 Clip · SKYRIZI · STELARA · SUTAB · Smart Pill · Sucraid · TRULANCE · Talicia · Trulance · VEGZELMA · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA · ZINPLAVA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (39%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for gastroenterology in FL.

Equivalent to $885 per 100 Medicare services performed
Looking for a gastroenterology in Miami?
Compare gastroenterologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
192
Per 100K population
7.2
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
3.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Leavitt is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), and high industry engagement (mixed engagement, top 9%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Leavitt experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Leavitt performed 1,270 infliximab infusion (remicade) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leavitt receive payments from pharmaceutical companies?
Yes. Dr. Leavitt received a total of $17,682 from 53 companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leavitt's costs compare to other gastroenterologys in Miami?
Dr. Leavitt's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leavitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →